ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Division Spotlight
Nuclear Nonproliferation Policy
The mission of the Nuclear Nonproliferation Policy Division (NNPD) is to promote the peaceful use of nuclear technology while simultaneously preventing the diversion and misuse of nuclear material and technology through appropriate safeguards and security, and promotion of nuclear nonproliferation policies. To achieve this mission, the objectives of the NNPD are to: Promote policy that discourages the proliferation of nuclear technology and material to inappropriate entities. Provide information to ANS members, the technical community at large, opinion leaders, and decision makers to improve their understanding of nuclear nonproliferation issues. Become a recognized technical resource on nuclear nonproliferation, safeguards, and security issues. Serve as the integration and coordination body for nuclear nonproliferation activities for the ANS. Work cooperatively with other ANS divisions to achieve these objective nonproliferation policies.
Meeting Spotlight
International Conference on Mathematics and Computational Methods Applied to Nuclear Science and Engineering (M&C 2025)
April 27–30, 2025
Denver, CO|The Westin Denver Downtown
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Apr 2025
Jan 2025
Latest Journal Issues
Nuclear Science and Engineering
June 2025
Nuclear Technology
May 2025
Fusion Science and Technology
Latest News
Sam Altman steps down as Oklo board chair
Advanced nuclear company Oklo Inc. has new leadership for its board of directors as billionaire Sam Altman is stepping down from the position he has held since 2015. The move is meant to open new partnership opportunities with OpenAI, where Altman is CEO, and other artificial intelligence companies.
H. L. Atkins, P. Richards, L. Schiffer
Nuclear Technology | Volume 2 | Number 1 | February 1966 | Pages 27-32
Technical Paper | doi.org/10.13182/NT66-A27563
Articles are hosted by Taylor and Francis Online.
The physical characteristics of 99mTc, including a short half-life of 6 h and a nearly monochromatic gamma emission of 140 keV, make it an excellent agent for scintillation scanning. Because of the short half-life and absence of significant beta emission, large amounts of activity may be used, the radiation dose to the patient being very low. Possibilities thus exist for greater resolution through optimal design of collimation and for more rapid scans because of better counting statistics. A colloid of this isotope has been prepared by passing hydrogen sulfide through a solution of 1 N HCl containing pertechnetate. This colloid, with an average blood disappearance half-time of 2.5 min, has proved useful in performing scintillation scans of liver, spleen, and bone marrow. A specially designed collimator of 721 holes has provided resolution comparable to the commercially available 31-hole collimator but with a sensitivity considerably greater than the 19-hole collimator. Maximum count rates over the liver are 75 000 to 100 000 counts/min following administration of 10 mCi of the colloid intravenously. Modification of a commercially available scanner has been made by bypassing the contrast enhancement circuits and doubling the speed in order to exploit the high count rates. Count rates over bone marrow are maximally 1/10 to 1/15 of the liver count, and spleen count rates fall in between liver and bone-marrow rates. Estimation of spleen size and extent of functioning marrow are possible in addition to detection of space-occupying disease of the liver.